Market Update (NYSE:LLY): U.S. federal agencies investigate Merck, Lilly drug pricing

[Reuters] – Drugmakers Merck & Co and Eli Lilly & Co are being investigated by the U.S. Attorney’s Office in Pennsylvania and other federal agencies over drug pricing practices, the companies disclosed. Merck, . . . → Read More: Market Update (NYSE:LLY): U.S. federal agencies investigate Merck, Lilly drug pricing Similar Articles: Market Update: Eli Lilly & Company (NYSE:LLY) – EXCLUSIVE-US insurers hold back Lilly’s death-defying diabetes drug Market Update: Eli Lilly & Company (NYSE:LLY) – FDA asks panel to weigh benefit, risk of Lilly lung cancer drug Company Update: Eli Lilly & Company (NYSE:LLY) – Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies